跳至主要内容
临床试验/NCT04768634
NCT04768634终止不适用

Predicting Arrhythmogenic Risk in Congenital Heart Patients: the PRECISION Study

Boston Children's Hospital2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2021年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
46
试验地点
2
主要终点
Number of patients with supraventricular tachycardia

研究概览

简要总结

In this research study we want to learn more about abnormal heart rhythm after cardiac surgery in children. These abnormal heart rhythms, also called arrhythmias, may occur due to several reasons after cardiac surgery. They can be due to abnormal electrical pathway or an irritable area of the heart that stimulates abnormal impulses. Regardless of the cause, arrhythmias after cardiac surgery can be a problem, extending the hospital stay, requiring additional medications and even leading to cardiac arrest.

Current practice is to monitor for arrhythmias after cardiac surgery, and to treat them if they occur. With this research, we want to investigate whether we can identify patients who will develop arrhythmia, and treat them before they occur.

详细描述

This is a prospective, randomized controlled trial of provocative electrophysiology testing and prophylactic treatment of inducible SVT versus expectant management

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged < 18 years of age on admission to the cardiac intensive care unit following cardiac surgery with a predicted probability of supraventricular tachycardia >10%

排除标准

  • Patients following orthotopic heart transplant, ventricular assist device implantation, primary extracorporeal membrane oxygenation cannulation, pacemaker or implantable cardioverter-defibrillator implantation or sympathectomy
  • Patients on antiarrhythmic medication at the time of surgery
  • Patients with atrioventricular conduction disease (1st degree atrioventricular block with PR interval greater than 200 ms, 2nd degree atrioventricular block or complete heart block)
  • Patients with severe ventricular dysfunction in whom therapy with beta-blocker or sotalol is deemed contra-indicated by the primary team
  • Patients with absent or non-functioning atrial pacing wires

结局指标

主要结局

Number of patients with supraventricular tachycardia

时间窗: Through hospital discharge after cardiac surgery, or up to 90 days

Number of days post-operatively at time of supraventricular tachycardia

次要结局

  • Number of days post-operatively in the intensive care unit(Though hospital discharge)
  • Number of patients with adverse events related to antiarrhythmic treatment(Through hospital discharge after cardiac surgery, or up to 90 days)
  • Number of patients with supraventricular tachycardia after hospital discharge(12 months)
  • Number of patients with sustained supraventricular tachycardia(Through hospital discharge after cardiac surgery, or up to 90 days)
  • Number of patients with other tachyarrhythmias(Through hospital discharge after cardiac surgery, or up to 90 days)
  • Number of days post-operatively at time of extubation(Through hospital discharge after cardiac surgery, or up to 90 days)
  • Number of patients with major adverse cardiac events (including need for CPR, ECMO or death)(Through hospital discharge after cardiac surgery, or up to 90 days)
  • Number of patients with adverse events related to provocative electrophysiology testing(Through hospital discharge after cardiac surgery, or up to 90 days)
  • Number of days in the hospital(Through hospital discharge after cardiac surgery, or up to 90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Audrey Dionne

Pediatric Cardiologist

Boston Children's Hospital

研究点 (2)

Loading locations...

相似试验